JAAD Game Changers: “The use of oral antibiotics before isotretinoin therapy in patients with acne” July 19, 2024 cccruser Post in Latest News Continue Reading→
Response to Hasan et al.’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.” July 19, 2024 cccruser Post in Latest News Continue Reading→
This Month in JAAD International: September 2024: Sun protection practices among skin cancer patients in Asia July 19, 2024 cccruser Post in Latest News Continue Reading→
JAAD Game Changers: “Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up” July 18, 2024 cccruser Post in Latest News Continue Reading→
JAAD Game Changers: “Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients” July 18, 2024 cccruser Post in Latest News Continue Reading→
JAAD Game Changers: “Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium” July 18, 2024 cccruser Post in Latest News Continue Reading→
JAAD Game Changers: “Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): A systematic review” July 18, 2024 cccruser Post in Latest News Continue Reading→
JAAD Game Changers: “Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort” July 18, 2024 cccruser Post in Latest News Continue Reading→
JAAD Game Changers: “Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study” July 18, 2024 cccruser Post in Latest News Continue Reading→
Increasing Survival for Melanoma with Bony Metastases in the Era of Novel Therapies: A Population-Based Retrospective Analysis July 17, 2024 cccruser Post in Latest News Continue Reading→